OSCR experienced a dramatic swing from $25.4M profit to -$443.2M loss despite 27.5% revenue growth, indicating severe operational challenges amid expansion.
The massive 1,842% decline in net income alongside strong revenue growth suggests fundamental issues with cost control, medical loss ratios, or integration costs from recent acquisitions. The company appears to be prioritizing growth over profitability, which raises concerns about sustainable business model execution in the competitive health insurance market.
While OSCR demonstrated strong top-line growth with revenue increasing 27.5% to $11.7B and significantly strengthened its cash position (+81.7% to $2.8B), the company swung dramatically from profitability to a $443.2M loss as operating income collapsed 792%. The substantial increase in liabilities (+39.8%) and current liabilities (+40.4%) outpacing asset growth, combined with the severe profit deterioration despite positive operating cash flow, suggests major operational inefficiencies or one-time charges that investors need to monitor closely for sustainability of the business model.
Net income declined 1842.5% — review whether driven by operations, interest costs, or non-recurring items.
Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.
Cash position surged 81.7% — strong cash generation or capital raise providing significant financial cushion.
Current assets grew 62.1% — improving short-term liquidity or inventory/receivables build.
Current liabilities surged 40.4% — significant near-term obligations; verify ability to meet short-term debt.
Liabilities grew 39.8% — significant increase in debt or obligations, assess impact on financial flexibility.
Asset base grew 30.7% — expansion through organic growth, acquisitions, or capital deployment.
Revenue growing 27.5% — solid top-line momentum, watch margins for quality of growth.
SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.
Operating cash flow grew 11.9% — strong conversion of earnings to cash, healthy business fundamentals.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →